These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 12373596

  • 1. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
    Becker JC, Terheyden P, Kämpgen E, Wagner S, Neumann C, Schadendorf D, Steinmann A, Wittenberg G, Lieb W, Bröcker EB.
    Br J Cancer; 2002 Oct 07; 87(8):840-5. PubMed ID: 12373596
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
    Voelter V, Schalenbourg A, Pampallona S, Peters S, Halkic N, Denys A, Goitein G, Zografos L, Leyvraz S.
    Melanoma Res; 2008 Jun 07; 18(3):220-4. PubMed ID: 18477897
    [Abstract] [Full Text] [Related]

  • 3. [Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].
    Cui CL, Chi ZH, Yuan XQ, Lian HY, Si L, Guo J.
    Ai Zheng; 2008 Aug 07; 27(8):845-50. PubMed ID: 18710619
    [Abstract] [Full Text] [Related]

  • 4. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma.
    Siegel R, Hauschild A, Kettelhack C, Kähler KC, Bembenek A, Schlag PM.
    Eur J Surg Oncol; 2007 Jun 07; 33(5):627-32. PubMed ID: 17196362
    [Abstract] [Full Text] [Related]

  • 5. Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
    Ridolfi L, Fiorentini G, Guida M, Michiara M, Freschi A, Aitini E, Ballardini M, Bichisao E, Ridolfi R, Italian Melanoma Intergroup.
    Melanoma Res; 2009 Apr 07; 19(2):100-5. PubMed ID: 19262411
    [Abstract] [Full Text] [Related]

  • 6. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P, Dreno B, Bureau B, Litoux P.
    Ann Dermatol Venereol; 1993 Apr 07; 120(6-7):437-40. PubMed ID: 8279787
    [Abstract] [Full Text] [Related]

  • 7. [Malignant melanoma of the uvea].
    Boaziz C, Mazeron JJ, Morere JF, Breau JL, Israël L.
    Bull Cancer; 1993 Jul 07; 80(7):577-83. PubMed ID: 8204938
    [Abstract] [Full Text] [Related]

  • 8. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
    Melichar B, Voboril Z, Lojík M, Krajina A.
    Hepatogastroenterology; 2009 Jul 07; 56(93):1157-62. PubMed ID: 19760961
    [Abstract] [Full Text] [Related]

  • 9. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
    Pyrhönen S, Hahka-Kemppinen M, Muhonen T, Nikkanen V, Eskelin S, Summanen P, Tarkkanen A, Kivelä T.
    Cancer; 2002 Dec 01; 95(11):2366-72. PubMed ID: 12436444
    [Abstract] [Full Text] [Related]

  • 10. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
    Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC.
    Clin Cancer Res; 2000 Aug 01; 6(8):3062-70. PubMed ID: 10955785
    [Abstract] [Full Text] [Related]

  • 11. Uveal melanoma: natural history and treatment options for metastatic disease.
    Wöll E, Bedikian A, Legha SS.
    Melanoma Res; 1999 Dec 01; 9(6):575-81. PubMed ID: 10661768
    [Abstract] [Full Text] [Related]

  • 12. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
    Niederkorn A, Wackernagel W, Artl M, Schwantzer G, Aigner B, Richtig E.
    Acta Ophthalmol; 2014 Dec 01; 92(8):e696-7. PubMed ID: 24774993
    [No Abstract] [Full Text] [Related]

  • 13. Intraarterial chemotherapy of malignant melanoma metastatic to the liver.
    Melichar B, Dvorák J, Jandík P, Tousková M, Solichová D, Megancová J, Voboril Z.
    Hepatogastroenterology; 2001 Dec 01; 48(42):1711-5. PubMed ID: 11813606
    [Abstract] [Full Text] [Related]

  • 14. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
    Schuster R, Lindner M, Wacker F, Krössin M, Bechrakis N, Foerster MH, Thiel E, Keilholz U, Schmittel A.
    Melanoma Res; 2010 Jun 01; 20(3):191-6. PubMed ID: 20335820
    [Abstract] [Full Text] [Related]

  • 15. Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment.
    Heusner TA, Antoch G, Wittkowski-Sterczewski A, Ladd SC, Forsting M, Verhagen R, Scheulen M.
    Rofo; 2011 Dec 01; 183(12):1151-60. PubMed ID: 22033849
    [Abstract] [Full Text] [Related]

  • 16. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
    Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U.
    Ann Oncol; 2014 Mar 01; 25(3):742-746. PubMed ID: 24510314
    [Abstract] [Full Text] [Related]

  • 17. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.
    Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, Meuli R, Gillet M, Lejeune F, Zografos L.
    J Clin Oncol; 1997 Jul 01; 15(7):2589-95. PubMed ID: 9215829
    [Abstract] [Full Text] [Related]

  • 18. Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients.
    Egerer G, Lehnert T, Max R, Naeher H, Keilholz U, Ho AD.
    Int J Clin Oncol; 2001 Feb 01; 6(1):25-8. PubMed ID: 11706523
    [Abstract] [Full Text] [Related]

  • 19. Artesunate in the treatment of metastatic uveal melanoma--first experiences.
    Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk JO, Baur A, Schuler G.
    Oncol Rep; 2005 Dec 01; 14(6):1599-603. PubMed ID: 16273263
    [Abstract] [Full Text] [Related]

  • 20. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C.
    Hepatogastroenterology; 2003 Dec 01; 50(54):1919-26. PubMed ID: 14696433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.